Socioeconomic Impact of Cancer in Latin America and The Caribbean: Socioeconomic Impact of Cancer in Latin America

• Autores: Werutsky, G, Gössling, G, Pellegrini, RA, Ampuero, GAS, Rebelatto, T
• Formato: revisión
• Fecha de Publicación: 2022
• Institución: Instituto Nacional de Enfermedades Neoplásicas
• Repositorio: INEN-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.inen.sld.pe:20.500.14703/289
• Enlace del recurso: https: //doi.org/10.1016/j.arcmed.2022.11.013; https://hdl.handle.net/20.500.14703/289
• Nivel de acceso: acceso abierto
• Materia: Cancer; Diagnosis; Latin America; Outcome; Socioeconomic; Treatment; https://purl.org/pe-repo/ocde/ford#3.02.21

The incidence of cancer in Latin America and the Caribbean (LAC) is increasing yearly and is expected to reach 2.4 million new cases by 2040, with a more pronounced effect in Central America and South America. In addition, cancer is already the most frequent cause of premature death for most countries in LAC, and the second cause of death independent of country socioeconomic status, clearly demonstrating that the cancer burden in LAC should be addressed now rather than considered as an issue to be dealt with in the future. LAC countries performed in a mid-range zone in terms of income and mortality-to-incidence ratio compared to other countries globally. The LAC continent has, in general, a median income per capita and a median availability of radiotherapy (RDT) machines per capita. Patients that have private health coverage are more likely to receive preventive care such as pap smears and mammography in many countries of the LAC. The human development index was negatively related to mortality from oral cancer in the LAC countries with medium and low Human Development Index (HDI). Cancer treatment adverse events can negatively affect survivors’ workability compromising their return to work after diagnosis. In conclusion, the cancer burden can be a major public health issue with a considerable socioeconomic impact in LAC countries. It is demonstrated in several studies that unequal access to optimal care is frequent in LAC and that health insurance type may impact patients’ diagnosis and outcome.